Biosimilars: the sector takes stock

The Biennial Activities Report 2021-2022 of the Spanish Association of Biosimilar Medicines, BioSim, puts figures to its activity. For example, the holding of more than 60 meetings with representatives of the executive and legislative sphere, both from the Government of Spain and from the different Autonomous Communities; the signing of 10 collaboration agreements with health agents to promote knowledge of biosimilar medicines; the development of various scientific and academic projects; and supporting patient education as a priority objective.

READ MORE